A new Stanford Medicine study reveals that colorblind men face 52% higher bladder cancer death risk because they can't see ...

A clinical trial evaluating the efficacy and safety of disitamab vedotin plus tislelizumab combined with re-TURBT in the treatment of HER-2-high expression (2+-3+) non-muscle invasive bladder cancer ...

The earliest symptoms of bladder cancer may go unnoticed by patients with colorblindness or similar color vision deficiencies ...

By Dr. Sanchari Sinha Dutta, Ph.D. A large electronic health record study suggests that difficulty recognizing painless blood ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Add Yahoo as a preferred source to see more of our stories on Google. Patients with advanced bladder cancer have significantly less risk of the disease progressing or returning when treated with an ...

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

A hearing on a motion by L’Oreal USA Inc. and other cosmetic companies challenging the claims by 15 plaintiffs that their bladder cancer was due to exposure to carcinogenic and endocrine-disrupting ...